BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10542248)

  • 1. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.
    Stacker SA; Stenvers K; Caesar C; Vitali A; Domagala T; Nice E; Roufail S; Simpson RJ; Moritz R; Karpanen T; Alitalo K; Achen MG
    J Biol Chem; 1999 Nov; 274(45):32127-36. PubMed ID: 10542248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
    Achen MG; Roufail S; Domagala T; Catimel B; Nice EC; Geleick DM; Murphy R; Scott AM; Caesar C; Makinen T; Alitalo K; Stacker SA
    Eur J Biochem; 2000 May; 267(9):2505-15. PubMed ID: 10785369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
    Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic processing regulates receptor specificity and activity of VEGF-C.
    Joukov V; Sorsa T; Kumar V; Jeltsch M; Claesson-Welsh L; Cao Y; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1997 Jul; 16(13):3898-911. PubMed ID: 9233800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
    Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG
    J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
    Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.
    Kukk E; Lymboussaki A; Taira S; Kaipainen A; Jeltsch M; Joukov V; Alitalo K
    Development; 1996 Dec; 122(12):3829-37. PubMed ID: 9012504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2.
    Kirkin V; Mazitschek R; Krishnan J; Steffen A; Waltenberger J; Pepper MS; Giannis A; Sleeman JP
    Eur J Biochem; 2001 Nov; 268(21):5530-40. PubMed ID: 11683876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
    Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF
    J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
    Dunk C; Ahmed A
    Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
    McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
    J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.
    Joukov V; Kumar V; Sorsa T; Arighi E; Weich H; Saksela O; Alitalo K
    J Biol Chem; 1998 Mar; 273(12):6599-602. PubMed ID: 9506953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
    Enholm B; Karpanen T; Jeltsch M; Kubo H; Stenback F; Prevo R; Jackson DG; Yla-Herttuala S; Alitalo K
    Circ Res; 2001 Mar; 88(6):623-9. PubMed ID: 11282897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.
    Arbiser JL; Larsson H; Claesson-Welsh L; Bai X; LaMontagne K; Weiss SW; Soker S; Flynn E; Brown LF
    Am J Pathol; 2000 Apr; 156(4):1469-76. PubMed ID: 10751370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.
    Lymboussaki A; Olofsson B; Eriksson U; Alitalo K
    Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF, its receptors and the tie receptors in recurrent miscarriage.
    Vuorela P; Carpén O; Tulppala M; Halmesmäki E
    Mol Hum Reprod; 2000 Mar; 6(3):276-82. PubMed ID: 10694277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.